BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire
· Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase..
· Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase..
While the 2024 US presidential campaign builds momentum, the United States and China are tumbling forth in their economic rivalry...
The Asia Pacific preventive vaccine market is booming, driven by its large population, rising healthcare spending, and focus on..